BIRC5 and neoplasm: The obtained data revealed that cell degeneration, necrosis, cellular inflammatory infiltration, tumor cells, cytoplasmic microvacuolation, giant cell, and immuno-expressions of CD68, TNF-α, and survivin significantly decreased in mono and dual treatment with APAN or/and ETO groups in comparison to the EST mice.